How to prepare for SEC’s climate-related disclosure rule
By 
Aaron Nicodemus2022-03-23T22:07:00
The Securities and Exchange Commission’s proposed climate-related disclosure rule would force companies that have been reluctant to initiate a self-examination of their environmental impact to do so, posthaste. Experts weigh in on where to start.
Related articles
-
ArticleSEC to reopen comment on climate-related disclosure rule, data breach reporting after glitch
The Securities and Exchange Commission will reopen comment periods on 11 rulemaking releases put forward over the past year, including proposals regarding climate-related disclosures and reporting cybersecurity breaches, because of a glitch in its online comment system.
-
PremiumESG Summit: How Rite Aid is preparing to comply with SEC’s climate disclosure rule
Amanda Patrick, Rite Aid’s director of ESG/corporate sustainability, shared the retail pharmacy chain’s sustainability journey so far and how it is readying to meet the SEC’s potential disclosure mandates during her keynote address at CW’s virtual ESG Summit.
-
ArticleNew environmental, social issues made for ‘unprecedented’ 2022 proxy season
Companies across many industries were kept on their toes during the 2022 proxy season, with shareholders filing an extraordinary number of proposals pertaining to a broad array of environmental and social issues.
More from Regulatory Policy
-
PremiumEU moves to simplify GDPR and AI Act obligations, raising compliance questions for companies
For the past decade, Europe has led in creating strong but flexible rules for data use and safe AI development. The EU’s new plans to simplify key data privacy and AI governance measures have received a mixed response.
-
News BriefSEC exam priorities for 2026 signal heightened focus on firmwide compliance
The U.S. Securities and Exchange Commission’s (SEC) Division of Examinations released its 2026 examination priorities, which give companies a roadmap of areas of heightened risk and regulatory focus for next year.
-
ArticlePharma sector boom puts pressure on compliance to counter financial crime
Regulation is a matter of life and death in the pharmaceutical industry. Rules to combat practices that can kill have been in force for decades, but tech developments are rapidly creating new risks and focusing lawmakers’ attention on areas where some compliance teams may lack experience.